199 related articles for article (PubMed ID: 35577065)
1. NADPH oxidase 2 activity in Parkinson's disease.
Keeney MT; Hoffman EK; Farmer K; Bodle CR; Fazzari M; Zharikov A; Castro SL; Hu X; Mortimer A; Kofler JK; Cifuentes-Pagano E; Pagano PJ; Burton EA; Hastings TG; Greenamyre JT; Di Maio R
Neurobiol Dis; 2022 Aug; 170():105754. PubMed ID: 35577065
[TBL] [Abstract][Full Text] [Related]
2. Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegeneration.
Tu D; Velagapudi R; Gao Y; Hong JS; Zhou H; Gao HM
Free Radic Biol Med; 2023 May; 200():47-58. PubMed ID: 36870375
[TBL] [Abstract][Full Text] [Related]
3. 2,5-Hexanedione induces dopaminergic neurodegeneration through integrin α
Zhang C; Hou L; Yang J; Che Y; Sun F; Li H; Wang Q
Cell Death Dis; 2018 Jan; 9(2):60. PubMed ID: 29352205
[TBL] [Abstract][Full Text] [Related]
4. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation.
Zhang W; Gao JH; Yan ZF; Huang XY; Guo P; Sun L; Liu Z; Hu Y; Zuo LJ; Yu SY; Cao CJ; Wang XM; Hong JS
Mol Neurobiol; 2018 Jan; 55(1):619-632. PubMed ID: 27975175
[TBL] [Abstract][Full Text] [Related]
5. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.
Zawada WM; Banninger GP; Thornton J; Marriott B; Cantu D; Rachubinski AL; Das M; Griffin WS; Jones SM
J Neuroinflammation; 2011 Oct; 8():129. PubMed ID: 21975039
[TBL] [Abstract][Full Text] [Related]
6. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
8. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
Tu D; Gao Y; Yang R; Guan T; Hong JS; Gao HM
J Neuroinflammation; 2019 Dec; 16(1):255. PubMed ID: 31805953
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.
Cristóvão AC; Guhathakurta S; Bok E; Je G; Yoo SD; Choi DH; Kim YS
J Neurosci; 2012 Oct; 32(42):14465-77. PubMed ID: 23077033
[TBL] [Abstract][Full Text] [Related]
10. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
De Miranda BR; Castro SL; Rocha EM; Bodle CR; Johnson KE; Greenamyre JT
Neurobiol Dis; 2021 Jun; 153():105312. PubMed ID: 33636387
[TBL] [Abstract][Full Text] [Related]
11. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
[TBL] [Abstract][Full Text] [Related]
12. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
13. Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.
Zhang W; Yan ZF; Gao JH; Sun L; Huang XY; Liu Z; Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Hu Y; Wang F; Hong JS; Wang XM
Mol Neurobiol; 2014 Jun; 49(3):1153-65. PubMed ID: 24277523
[TBL] [Abstract][Full Text] [Related]
14. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.
Di Maio R; Barrett PJ; Hoffman EK; Barrett CW; Zharikov A; Borah A; Hu X; McCoy J; Chu CT; Burton EA; Hastings TG; Greenamyre JT
Sci Transl Med; 2016 Jun; 8(342):342ra78. PubMed ID: 27280685
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
17. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
Harrison IF; Smith AD; Dexter DT
Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
[TBL] [Abstract][Full Text] [Related]
18. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
Hou L; Liu J; Sun F; Huang R; Chang R; Ruan Z; Wang Y; Zhao J; Wang Q
J Neuroinflammation; 2023 Feb; 20(1):42. PubMed ID: 36804009
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidative stress in Parkinson's disease.
Dias V; Junn E; Mouradian MM
J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
[TBL] [Abstract][Full Text] [Related]
20. Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway.
Hou L; Wang K; Zhang C; Sun F; Che Y; Zhao X; Zhang D; Li H; Wang Q
Redox Biol; 2018 Apr; 14():250-260. PubMed ID: 28978491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
